349 information-security-"https:"-"https:"-"https:"-"https:"-"https:"-"Dr" positions at NIST in United States
Sort by
Refine Your Search
-
. Metagenomics is able to evaluate the presence of different taxa or specific genes while transcriptomics is able to define levels of gene expression, but proteomics seeks to identify and measure the translated
-
Description We are studying the mechanism by which DNA partitions into and threads through single nanometer-scale pores. This experimental and theoretical effort focuses on understanding how genetic information
-
is how to calibrate the response of these detectors. When individual photon number pulses can be resolved, the problem is relatively straightforward and can be regarded as solved. This covers the range
-
50.61.01.C0300 Gaithersburg, MD NIST only participates in the February and August reviews. Advisers name email phone William D Ratcliff william.ratcliff@nist.gov 301.975.4316 Description It has become
-
@nist.gov 301 975 2093 Description This opportunity focuses on the development of analytical methods and/or data processing techniques that could be used to advance drug detection and identification (or drug
-
Description The translation of a mass spectrum into a chemical identification is often a very imprecise and error prone part of the rapidly expanding fields of mass spectrometry-based proteomics and
-
50.68.62.B8409 Boulder, CO NIST only participates in the February and August reviews. Advisers name email phone Martin J. Stevens marty@nist.gov 303.497.4740 Description Our group is developing chip-scale
-
-to illuminate the structural transformations that occur across phases. The optical characterization of biological molecules using vibrational spectroscopy supplies critical, detailed structural information
-
electron excited X-ray microanalysis has been the electron probe microanalyzer with wavelength dispersive spectrometer (EPMA/WDS). On the other hand, energy dispersive X-ray microanalysis is often viewed as
-
are essential for broad adoption of these methods, this postdoc would collaborate with a unique array of technology and informatics developers in the Genome in a Bottle Consortium to develop authoritative de novo